| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BRAINRES.2004.05.029 |
| P698 | PubMed publication ID | 15261108 |
| P2093 | author name string | Andrew A Parsons | |
| Jill C Richardson | |||
| David R Howlett | |||
| Simon T Bate | |||
| D Ceri Davies | |||
| Angela Austin | |||
| M Isabel Gonzalez | |||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 130-136 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes | |
| P478 | volume | 1017 |
| Q30455082 | APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD). |
| Q37820330 | APP transgenic mice: their use and limitations |
| Q33964297 | Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease |
| Q55253035 | Age-Related Increase of Insulin-Degrading Enzyme Is Inversely Correlated with Cognitive Function in APPswe/PS1dE9 Mice. |
| Q89152821 | Altered Cortical and Hippocampal Excitability in TgF344-AD Rats Modeling Alzheimer's Disease Pathology |
| Q30499574 | Alzheimer disease models and human neuropathology: similarities and differences |
| Q36718919 | Analysis of protein glycation using fluorescent phenylboronate gel electrophoresis |
| Q30503957 | Anesthesia in presymptomatic Alzheimer's disease: a study using the triple-transgenic mouse model |
| Q94601929 | Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice |
| Q35034130 | Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease |
| Q28580198 | Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death |
| Q35107567 | Bioinformatic prediction and confirmation of beta-adducin as a novel substrate of glycogen synthase kinase 3. |
| Q50559330 | Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo |
| Q35571874 | Changes in brain β-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice |
| Q37230895 | Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice |
| Q53316981 | Characterization of the brain β-amyloid isoform pattern at different ages of Tg2576 mice. |
| Q48431434 | Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of Alzheimer disease: effects of melatonin or ramelteon. |
| Q48114506 | Clusterin associates specifically with Aβ40 in Alzheimer's disease brain tissue |
| Q47597706 | Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression |
| Q33611723 | Computational identification of potential multitarget treatments for ameliorating the adverse effects of amyloid-β on synaptic plasticity |
| Q57075083 | Continual Trials Spontaneous Recognition Tasks in Mice: Reducing Animal Numbers and Improving Our Understanding of the Mechanisms Underlying Memory |
| Q47303965 | Detection of Aβ plaque-associated astrogliosis in Alzheimer's disease brain by spectroscopic imaging and immunohistochemistry |
| Q34732336 | Dietary (-)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing. |
| Q49333511 | Disparate Effects of Lithium and a GSK-3 Inhibitor on Neuronal Oscillatory Activity in Prefrontal Cortex and Hippocampus |
| Q27335191 | Early-onset and robust amyloid pathology in a new homozygous mouse model of Alzheimer's disease |
| Q98778829 | Effect of Moxibustion on Behavioral Changes and Expression of APP and BACE1 in Hippocampus of SAMP8 Mice |
| Q48715143 | Effects of Alzheimer's disease transgenes on neurochemical expression in the mouse brain determined by ¹H MRS in vitro |
| Q93108507 | Effects of Moxibustion and Moxa Smoke on Behavior Changes and Energy Metabolism in APP/PS1 Mice |
| Q90568409 | Effects of rising amyloidβ levels on hippocampal synaptic transmission, microglial response and cognition in APPSwe/PSEN1M146V transgenic mice |
| Q64102309 | F-FDG-PET in Mouse Models of Alzheimer's Disease |
| Q36317638 | F-spondin gene transfer improves memory performance and reduces amyloid-β levels in mice |
| Q36066679 | First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression |
| Q33427814 | Gender- and age-dependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease |
| Q51719057 | Gender-specificities in Alzheimer's disease and mild cognitive impairment. |
| Q36524290 | Gene Therapy Models of Alzheimer's Disease and Other Dementias |
| Q34189447 | Gene-environment interaction research and transgenic mouse models of Alzheimer's disease |
| Q30758233 | Hippocampal neurochemical changes in senescent mice induced with chronic injection of D-galactose and NaNO₂: an in vitro high-resolution NMR spectroscopy study at 9.4T. |
| Q61660061 | Hyperspectral analysis applied to micro-Brillouin maps of amyloid-beta plaques in Alzheimer's disease brains |
| Q35694088 | Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease |
| Q89485048 | Impaired chronic pain-like behaviour and altered opioidergic system in the TASTPM mouse model of Alzheimer's disease |
| Q36310518 | Locus Coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease |
| Q36044265 | Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease |
| Q37530392 | Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model |
| Q50702084 | Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer's disease mouse models |
| Q40267937 | MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease |
| Q34325302 | Magnetic resonance spectroscopy in vivo of neurochemicals in a transgenic model of Alzheimer's disease: a longitudinal study of metabolites, relaxation time, and behavioral analysis in TASTPM and wild-type mice |
| Q97423813 | MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer's disease pathogenesis |
| Q36938165 | Modeling Alzheimer's disease: from past to future |
| Q49015305 | Models of dementia: an introductory overview |
| Q90720255 | Moving towards a more realistic concept of what constitutes Alzheimer's disease |
| Q94599572 | N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease |
| Q34149384 | NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice |
| Q52584637 | Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease. |
| Q40199218 | Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo |
| Q51692938 | PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease. |
| Q36635583 | Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo |
| Q36102989 | Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis |
| Q48452062 | Progressive cognitive decline in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe. |
| Q37265855 | Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer's disease |
| Q37272217 | Reduction of synaptojanin 1 accelerates Aβ clearance and attenuates cognitive deterioration in an Alzheimer mouse model. |
| Q35663346 | Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenes |
| Q50288922 | Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals. |
| Q37180013 | Role of endoplasmic reticulum Ca2+ signaling in the pathogenesis of Alzheimer disease |
| Q36473640 | Sex and gonadal hormones in mouse models of Alzheimer's disease: what is relevant to the human condition? |
| Q59544086 | Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts |
| Q34532864 | Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease |
| Q38036916 | Targeting synaptic dysfunction in Alzheimer's disease therapy. |
| Q47570646 | The Continuing Failure of Bexarotene in Alzheimer's Disease Mice. |
| Q33795218 | The Effects of Physiological and Methodological Determinants on 18F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model |
| Q37350660 | The Role of Capsaicin-induced Acute Inactivation of C-fibers on Tactile Learning in Rat. |
| Q64981048 | The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease. |
| Q28756691 | The role of positive selection in determining the molecular cause of species differences in disease |
| Q60045412 | Transgenic Mouse Models as Tools for Understanding How Increased Cognitive and Physical Stimulation Can Improve Cognition in Alzheimer's Disease |
| Q47139291 | Viscoelasticity of amyloid plaques in transgenic mouse brain studied by Brillouin microspectroscopy and correlative Raman analysis |
| Q36877633 | β amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease mice |
Search more.